Главная
Рынки
Графики и идеи
Алготрейдинг
Новости
Store
Брокеры
Скачать
Экономический календарь
Торговые сигналы
Вебтерминал
Нажмите
/
для поиска: @user, $symbol, ...
Поиск
Вход
Создать аккаунт
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ACAD
#1237
Acadia Pharmaceuticals Inc.
24.5
6
+1.24%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
Годовой диапазон
Дневное изменение
+1.24%
Месячное изменение
-6.83%
6-месячное изменение
-7.08%
Годовое изменение
+28.05%
Предыдущее закрытие
24.2
6
Open
24.5
6
Bid
Ask
Low
24.5
6
High
24.5
6
Объем
140
Рынки
Рынок акций США
Здравоохранение
ACAD
Open full chart
Financials
Overview
Отчетность
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
160.05 M
161.2 M
162.23 M
164.77 M
166.79 M
170.49 M
—
Valuation ratios
Enterprise value
8.23 B
3.62 B
2.53 B
4.9 B
2.74 B
4.38 B
13.68 B
Price to earnings ratio
—
—
-12.18
-83.41
13.49
11.61
53.72
Price to sales ratio
—
—
0.01
0.01
3.19
—
—
Price to cash flow ratio
—
—
-0.02
0.3
19.36
41.32
97.09
Price to book ratio
—
—
0.01
0.01
4.17
3.7
7.12
Enterprise value to EBITDA ratio
-29.83
-22.27
-11.29
-61.66
7.43
—
—
Profitability ratios
Return on assets %
0.36
0.24
0.37
0.08
0.19
0.25
0.27
Return on equity %
0.45
0.31
0.54
0.14
0.31
0.32
0.36
Return on invested capital %
2 612.98
927.62
1 116.07
331.41
423.81
-90.92
6.7
Gross margin %
97.69
97.76
98.03
94.27
91.46
91.69
366.81
Operating margin %
64.87
35.2
43.23
10.1
24.1
9.78
39.09
EBITDA margin %
-62.46
-33.53
-43.37
-10.93
38.52
9.36
37.34
Net margin %
63.74
34.67
41.76
8.44
23.64
36.49
139.94
Liquidity ratios
Quick ratio
6.68
6.28
3.95
2.26
2.14
3.43
11.27
Current ratio
6.77
6.43
4.04
2.42
2.38
3.83
12.64
Inventory turnover
1.27
0.91
0.79
1.6
1.24
0.88
0.85
Asset turnover
0.56
0.65
0.8
1.09
0.99
0.78
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
0.71
0.1
0.95
0.65
0.65
EBIT per share
—
—
-1.38
-0.47
2.18
0.55
0.46
EBITDA per share
—
—
-1.39
-0.48
2.22
0.59
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
2.58
2.68
4.54
4.82
18.37
Net current asset value per share
—
—
3.14
3.76
5.64
6.25
23.45
Tangible book value per share
—
—
2.48
2.24
3.68
6.58
19.37
Working capital per share
—
—
2.36
2.21
3.27
4.62
15.97
Book value per share
—
—
2.48
2.64
4.4
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Новости
ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth
제퍼리스, 가이던스 상향에 아카디아 파마슈티컬스 목표 주가 올려
Jefferies raises Acadia Pharmaceuticals stock price target on guidance
시티즌스, Acadia Pharmaceuticals 목표가 상향 조정
Citizens raises Acadia Pharmaceuticals price target on growth outlook
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript
ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ACAD) 2026-02-25
Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates
ACADIA Q4 2025 slides: $1B revenue milestone as both drugs post double-digit growth
아카디아 실적 발표 예정: 수익 압박에도 매출 성장 기대
울프 리서치, 아카디아 주식 ’시장수익률 상회’로 개시
Wolfe Research initiates Acadia stock with outperform rating